Gülhane Eğitim ve Araştırma Hastanesi

Ankara 6010

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Hepatocellular, Small-Cell Lung Cancer

Studies at this site

• A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer — Running, not enrolling
• Regorafenib-pembrolizumab vs. TACE/TARE in Intermediate Stage HCC Beyond Up-to-7 — Stopped early